MAPT and Alzheimer disease: Over the last decade, numerous studies including ours demonstrated that exogeneous application of soluble tau assemblies can cause rapid and lasting impairment of synaptic function, suggesting a significant role in mediating synaptotoxicity in several neurological illnesses, including AD and other tauopathies.